Goldman Sachs’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-994,696
| Closed | -$540K | – | 4746 |
|
|
2016
Q3 | $540K | Buy |
994,696
+36,281
| +4% | +$19.7K | ﹤0.01% | 3396 |
|
|
2016
Q2 | $557K | Buy |
958,415
+319,433
| +50% | +$186K | ﹤0.01% | 3260 |
|
|
2016
Q1 | $933K | Buy |
638,982
+16,011
| +3% | +$23.4K | ﹤0.01% | 2901 |
|
|
2015
Q4 | $1.99M | Buy |
622,971
+5,045
| +0.8% | +$16.1K | ﹤0.01% | 2524 |
|
|
2015
Q3 | $3.86M | Sell |
617,926
-1,459,769
| -70% | -$9.12M | ﹤0.01% | 2159 |
|
|
2015
Q2 | $20.6M | Buy |
2,077,695
+830,605
| +67% | +$8.25M | 0.01% | 1330 |
|
|
2015
Q1 | $9.19M | Buy |
1,247,090
+170,924
| +16% | +$1.26M | ﹤0.01% | 1706 |
|
|
2014
Q4 | $5.76M | Buy |
1,076,166
+229,037
| +27% | +$1.23M | ﹤0.01% | 1904 |
|
|
2014
Q3 | $4.26M | Buy |
847,129
+3,412
| +0.4% | +$17.2K | ﹤0.01% | 2076 |
|
|
2014
Q2 | $5.66M | Buy |
843,717
+233,015
| +38% | +$1.56M | ﹤0.01% | 1921 |
|
|
2014
Q1 | $4.42M | Sell |
610,702
-9,998
| -2% | -$72.4K | ﹤0.01% | 2082 |
|
|
2013
Q4 | $2.34M | Buy |
+620,700
| New | +$2.34M | ﹤0.01% | 2523 |
|